Fund profile
Tickers
BGHDX, BGHBX
Fund manager
Total assets
$20.19 mm
Liabilities
$31.53 k
Net assets
$20.16 mm
Number of holdings
35.00
35 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ARGX Argen X SE | 1.68 mm | 3.44 k shares | 8.35 | Common equity | Long | Netherlands |
GMAB Genmab | 1.56 mm | 4.39 k shares | 7.72 | Common equity | Long | Denmark |
ALNY Alnylam Pharmaceuticals Inc | 1.35 mm | 7.64 k shares | 6.71 | Common equity | Long | USA |
MRNA Moderna Inc | 1.17 mm | 11.32 k shares | 5.80 | Common equity | Long | USA |
ABMD Abiomed Inc | 1.04 mm | 5.22 k shares | 5.15 | Common equity | Long | USA |
Sartorius AG | 1.03 mm | 3.03 k shares | 5.10 | Preferred equity | Long | Germany |
Wuxi Biologics Cayman Inc
|
897.93 k | 154.50 k shares | 4.45 | Common equity | Long | China |
EXAS Exact Sciences Corp. | 851.93 k | 12.49 k shares | 4.23 | Common equity | Long | USA |
DXCM Dexcom Inc | 846.23 k | 9.07 k shares | 4.20 | Common equity | Long | USA |
EW Edwards Lifesciences Corp | 764.16 k | 11.03 k shares | 3.79 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 749.80 k | 18.18 k shares | 3.72 | Common equity | Long | USA |
Ambu A/S
|
749.14 k | 71.87 k shares | 3.72 | Common equity | Long | Denmark |
ILMN Illumina Inc | 682.97 k | 4.98 k shares | 3.39 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 647.60 k | 14.28 k shares | 3.21 | Common equity | Long | USA |
M3 Inc
|
634.86 k | 35.00 k shares | 3.15 | Common equity | Long | Japan |
VEEV Veeva Systems Inc - Ordinary Shares | 573.93 k | 2.82 k shares | 2.85 | Common equity | Long | USA |
ALK-Abello A/S
|
538.81 k | 48.04 k shares | 2.67 | Common equity | Long | Denmark |
DOCS Doximity Inc - Ordinary Shares | 451.86 k | 21.29 k shares | 2.24 | Common equity | Long | USA |
RMD Resmed Inc. | 422.17 k | 2.86 k shares | 2.09 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 368.85 k | 3.94 k shares | 1.83 | Common equity | Long | Denmark |
MASI Masimo Corp | 362.56 k | 4.14 k shares | 1.80 | Common equity | Long | USA |
STAA Staar Surgical Co. | 316.02 k | 7.87 k shares | 1.57 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 310.50 k | 40.59 k shares | 1.54 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 296.97 k | 14.40 k shares | 1.47 | Common equity | Long | USA |
HCAT Health Catalyst Inc | 251.03 k | 24.81 k shares | 1.25 | Common equity | Long | USA |
TDOC Teladoc Health Inc | 225.81 k | 12.15 k shares | 1.12 | Common equity | Long | USA |
EXAI Exscientia Plc | 161.60 k | 35.75 k shares | 0.80 | Common equity | Long | UK |
Zai Lab Ltd
|
159.28 k | 65.09 k shares | 0.79 | Common equity | Long | China |
RLAY Relay Therapeutics Inc | 148.81 k | 17.69 k shares | 0.74 | Common equity | Long | USA |
NVCR NovoCure Ltd | 130.56 k | 8.08 k shares | 0.65 | Common equity | Long | Jersey |
ALEC Alector Inc | 110.22 k | 17.01 k shares | 0.55 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 78.39 k | 3.81 k shares | 0.39 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 69.27 k | 7.39 k shares | 0.34 | Common equity | Long | USA |
LYEL Lyell Immunopharma Inc | 45.69 k | 31.08 k shares | 0.23 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 24.91 k | 6.44 k shares | 0.12 | Common equity | Long | USA |